
Jeplus.in
Purchase All Medicines.Get 10% Offer

Pharma Tech
KOLs interviewed by GlobalData consistently recognized tirzepatide's cardiometabolic value as extending well beyond weight loss alone.

Pharma Tech
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied

Express Pharma
In a regulatory filing, the company said the transaction was completed on August 31, 2026 The post Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore appeared first on Express Pharma.

Pharma Tech
These White House deals will require the nine midsize pharma companies to provide MFN prices to state Medicaid programmes nationally.

Pharma Tech
Merida's lead programme, MER511, is in Phase I development for Graves' disease and thyroid eye disease (TED).
Sponsored content

Purchase All Medicines.Get 10% Offer
News
ET Pharma
Sep 2, 2026, 2:19 AM
Simcere is also eligible to receive up to about $1.46 billion in payments for unspecified milestones.
Pharma Tech
Sep 1, 2026, 6:53 PM
KOLs interviewed by GlobalData consistently recognized tirzepatide's cardiometabolic value as extending well beyond weight loss alone.
Pharma Tech
Sep 1, 2026, 1:59 PM
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied
PharmaShots
Sep 1, 2026, 12:30 PM
Shots: Ref: Cortec | Image: Cortec | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system appeared first on PharmaShots.
PharmaShots
Sep 1, 2026, 12:30 PM
Shots: Company: Biocon Product: Yesafili Active Ingredient: Aflibercept Reference Product: Eylea Reference Product Company: Bayer Disease: All Approved Indications Date: Aug 03, 2026 Shots: Company: Fresenius Kabi & Dr Reddy’s Laboratories Product: Rituximab Active Ingredient: Rituximab Reference Product: Rituxan Reference Product Company: Genentech & Biogen Disease: All Approved Indications Date: Aug 03, 2026 Shots: Company: Samsung Bioepis Product: Opuviz Active Ingredient: Aflibercept Reference Product: Eylea Reference Product Company: Bayer Disease: All Approved Indications Date: Aug 10, 2026 Shots: … The post Key Biosimilars Events of August 2026 appeared first on PharmaShots.
ET Pharma
Sep 1, 2026, 12:16 PM
Under the agreement, the chinese drugmaker is entitled to receive up to $123 million in upfront, development and regulatory milestone along with double-digit royalties on annual sales.
News
Google News
Sep 2, 2026, 4:24 AM
For SK Biopharm, the Next Drug Discovery Lab Is Packed With GPUs Koreabizwire
Google News
Sep 2, 2026, 3:25 AM
Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued? simplywall.st
Google News
Sep 1, 2026, 11:21 PM
Employees rise with yeast, biotech giant chinadaily.com.cn
Google News
Sep 1, 2026, 10:44 PM
Novartis MS pill beats older drug in trials, boosts pipeline hopes Reuters
Google News
Sep 1, 2026, 10:44 PM
Sun Pharma offers US cheaper drug supply The Times of India
Google News
Sep 1, 2026, 9:36 PM
TraceIQ Launched to Maximize Pharmaceutical Traceability Genetic Engineering and Biotechnology News
Google News
Sep 1, 2026, 9:00 PM
Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award Yahoo! Finance Canada
Google News
Sep 1, 2026, 8:55 PM
Nine drugmakers join US most-favored-nation plan BioXconomy
Google News
Sep 1, 2026, 8:55 PM
Nasus Pharma (NYSE: NSRX) sets $50M share shelf for working capital and drug development Stock Titan
Sponsored placement

Purchase All Medicines.Get 10% Offer